Table 1.
Demographic and clinical characteristics of COVID-19 patients
No | (%) | |
---|---|---|
Age (years) | ||
≤ 65 | 144 | 48.0 |
> 65 | 156 | 52.0 |
Median (Range) | 66.00 (36–85) | |
Sex | ||
Male | 169 | 56.3 |
Female | 131 | 43.7 |
Smoking | ||
No | 182 | 60.7 |
Yes | 118 | 39.3 |
Vaccination(AstraZeneca or Pfizer) | ||
No | 92 | 30.7 |
Yes | 208 | 69.3 |
Co-morbid diseases | ||
None | 91 | 30.3 |
Hypertension | 107 | 35.7 |
Liver disease | 17 | 5.7 |
Renal disease | 39 | 13.0 |
DM | 78 | 26.0 |
Thyroid disease | 12 | 4.0 |
Heart disease | 13 | 4.3 |
Clinical course | ||
Mild or moderate illness | 156 | 52.0 |
Severe or critical illness | 144 | 48.0 |
Symptoms | ||
Fever | 73 | 24.3 |
Sore throat | 110 | 36.7 |
Dry cough | 161 | 53.7 |
Headache | 69 | 23.0 |
Dyspnea | 144 | 48.0 |
Diarrhea | 21 | 7.0 |
Myalgia | 123 | 41.0 |
Fatigue | 165 | 55.0 |
Nausea | 44 | 4.7 |
Vomiting | 15 | 5.0 |
Anosmia | 85 | 28.3 |
Gustatory dysfunction | 69 | 23.0 |
Dysarthria | 9 | 3.0 |
DM Diabetes Mellitus, No number, % percentage